subject area of
- A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma Academic Article
- A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial Academic Article
- Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices Academic Article
- Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs Academic Article
- Cost-effectiveness of umeclidinium as add-on to ICS/LABA therapy in COPD: A UK perspective Academic Article
- Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open Academic Article
- Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting. Academic Article
- Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial Academic Article
- Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases Academic Article
- New Applications for Traditional Drugs in Inflammatory Bowel Disease Academic Article
- Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis Academic Article
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Academic Article
- Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10 Academic Article
- Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial Academic Article
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease Academic Article